Convergence Investment Partners, LLC Zoetis Inc. Transaction History

Convergence Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$81.56 - $100.67 $795,291 - $981,633	-9,751 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$79.28 - $95.27 $801,520 - $963,179	-10,110 Reduced 50.9%	9,751 $834,000
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $861,970 - $962,413	-10,323 Reduced 34.2%	19,861 $1.82 Million
Q2 2018 Aug 07, 2018	BUY	$79.9 - $89.2 $2.34 Million - $2.62 Million	29,324 Added 3409.77%	30,184 $2.57 Million
Q1 2018 May 14, 2018	BUY	$71.51 - $84.69 $61,498 - $72,833	860 New	860 $72,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.